{"disease":{"id":"venolymphatic-malformation","name":"venolymphatic malformation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04409145","title":"First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Venthera, Inc., a BridgeBio company","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}